http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#head http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#provenance http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://rdf.disgenet.org/resource/gda/DGN541250ecf54810359f017dde9e1032a8 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/2099 http://rdf.disgenet.org/resource/gda/DGN541250ecf54810359f017dde9e1032a8 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0006142 http://rdf.disgenet.org/resource/gda/DGN541250ecf54810359f017dde9e1032a8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#provenance http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://purl.org/dc/terms/description [We analyzed three series of de novo stage II-III breast cancer patients treated front line with anthracycline-based regimens of various cyclophosphamide dose intensities: 65 patients with estrogen receptor (ER)(-) tumors treated with anthracyclines alone (Institut Jules Bordet, Brussels), 51 unselected breast cancer patients treated with intermediate doses of cyclophosphamide (MD Anderson Cancer Center, Houston, TX), and 128 others treated with a dose-dense anthracycline-cyclophosphamide combination (St. Louis, Paris).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/20228131 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/dc/terms/created 2017-10-17T13:12:29+02:00 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP362141.RAaN_1weEVfMA-tj42eX1qGtnvl-hpUpxnV3wNK21d7Mo http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0